Silvia Baiguera

Silvia Baiguera

Auto-generated profile, based on publicly available information

Silvia Baiguera

INAIL-DIPIA, Via Alessandria 220E, 00198 Rome, Italy

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2012 in Journal of Biomedical Materials Research Part B: Applied Biomaterials
Verified
Journal Article
Closed access
PDF file
SBSilvia Baiguera
Silvia Baiguera
PMPaolo Macchiarini
Paolo Macchiarini
DRDomenico Ribatti
Domenico Ribatti

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SBSilvia Baiguera
Silvia Baiguera
CGCostantino Del Gaudio
Costantino Del Gaudio
PNPaolo Di Nardo
Paolo Di Nardo
VMVittorio Manzari
Vittorio Manzari
FCFelicia Carotenuto
Felicia Carotenuto
LTLaura Teodori
Laura Teodori
Functional engineered muscles are still a critical clinical issue to be addressed, although different strategies have been considered so far for the treatment of severe muscular injuries. Indeed, the regenerative capacity of skeletal muscle (SM) results inadequate for large‐scale defects, and currently, SM reconstruction remains a complex and unsolved task. For this aim, tissue engineered muscles should provide a proper biomimetic extracellular matrix (ECM) alternative, characterized by an aligned/microtopographical structure and a myogenic microenvironment, in order to promote muscle regeneration. As a consequence, both materials and fabrication techniques play a key role to plan an effective therapeutic approach. Tissue‐specific decellularized ECM (dECM) seems to be one of the most promising material to support muscle regeneration and repair. 3D printing technologies, on the other side, enable the fabrication of scaffolds with a fine and detailed microarchitecture and patient‐specific implants with high structural complexity. To identify innovative biomimetic solutions to develop engineered muscular constructs for the treatment of SM loss, the more recent (last 5 years) reports focused on SM dECM‐based scaffolds and 3D printing technologies for SM regeneration are herein reviewed. Possible design inputs for 3D printed SM dECM‐based scaffolds for muscular regeneration are also suggested.

27 August 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SBSilvia Baiguera
Silvia Baiguera
LULuca Urbani
Luca Urbani
CGCostantino Del Gaudio
Costantino Del Gaudio
It is commonly stated that tissue engineering is the most promising approach to treat or replace failing tissues/organs. For this aim, a specific strategy should be planned including proper selection of biomaterials, fabrication techniques, cell lines, and signaling cues. A great effort has been pursued to develop suitable scaffolds for the restoration of a variety of tissues and a huge number of protocols ranging fromin vitrotoin vivostudies, the latter further differentiating into several procedures depending on the type of implantation (i.e., subcutaneous or orthotopic) and the model adopted (i.e., animal or human), have been developed. All together, the published reports demonstrate that the proposed tissue engineering approaches spread toward multiple directions. The critical review of this scenario might suggest, at the same time, that a limited number of studies gave a real improvement to the field, especially referring toin vivoinvestigations. In this regard, the present paper aims to review the results ofin vivotissue engineering experimentations, focusing on the role of the scaffold and its specificity with respect to the tissue to be regenerated, in order to verify whether an extracellular matrix-like device, as usually stated, could promote an expected positive outcome.

28 April 2019 in Journal of Healthcare Engineering
Verified
Journal Article
Open access
PDF file
ESElisa Scatena
Elisa Scatena
SBSilvia Baiguera
Silvia Baiguera
CGCostantino Del Gaudio
Costantino Del Gaudio
Raman spectroscopy is a powerful optical technique based on the inelastic scattering of incident light to assess the chemical composition of a sample, including biological ones. Medical diagnostic applications of Raman spectroscopy are constantly increasing to provide biochemical and structural information on several specimens, being not affected by water interference, and potentially avoiding the constraint of additional labelling procedures. New strategies have been recently developed to overcome some Raman limitations related, for instance, to the need to deal with an adequate quantity of the sample to perform a reliable analysis. In this regard, the use of metallic nanoparticles, the optimization of fiber optic probes, and other approaches can actually enhance the signal intensity compared to spontaneous Raman scattering. Moreover, to further increase the potential of this investigation technique, aptamers can be considered as a valuable means, being synthetic, short, single, or double-stranded oligonucleotides (RNAs or DNAs) that fold up into unique 3D structures to specifically bind to selected molecules, even at very low concentrations, and thus allowing an early diagnosis of a possible disease. Due to the paramount relevance of the topic, this review focuses on the main Raman spectroscopy techniques combined with aptamer arrays in the label-free mode, providing an overview on different applications to support healthcare management.

28 September 2016 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
SBSilvia Baiguera
Silvia Baiguera
SASvetlana Arkhipva
Svetlana Arkhipva
DYDengping Yin
Dengping Yin
MHMark Holterman
Mark Holterman
PMPaolo Macchiarini
Paolo Macchiarini

17 September 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MLMei Ling Lim
Mei Ling Lim
BOBrandon Nick Sern Ooi
Brandon Nick Sern Ooi
PJPhilipp Jungebluth
Philipp Jungebluth
SSSebastian Sjöqvist
Sebastian Sjöqvist
IHIsabell Hultman
Isabell Hultman
PMPaolo Macchiarini
Paolo Macchiarini
Stem cells contribute to regeneration of tissues and organs. Cells with stem cell-like properties have been identified in tumors from a variety of origins, but to our knowledge there are yet no reports on tumor-related stem cells in the human upper respiratory tract. In the present study, we show that a tracheal mucoepidermoid tumor biopsy obtained from a 6 year-old patient contained a subpopulation of cells with morphology, clonogenicity and surface markers that overlapped with bone marrow mesenchymal stromal cells (BM-MSCs). These cells, designated as MEi (mesenchymal stem cell-like mucoepidermoid tumor) cells, could be differentiated towards mesenchymal lineages both with and without induction, and formed spheroids in vitro. The MEi cells shared several multipotent characteristics with BM-MSCs. However, they displayed differences to BM-MSCs in growth kinectics and gene expression profiles relating to cancer pathways and tube development. Despite this, the MEi cells did not possess in vivo tumor-initiating capacity, as proven by the absence of growth in situ after localized injection in immunocompromised mice. Our results provide an initial characterization of benign tracheal cancer-derived niche cells. We believe that this report could be of importance to further understand tracheal cancer initiation and progression as well as therapeutic development.